TLPH · Talphera, Inc. · Earnings Calls, Transcripts & Webcasts
$0.79
+0.05 (+6.25%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 12, 2026
Market Cap
$40.80M
Shares
51.96M
Volume · Nov 20
357.32K
Avg daily vol (3M)
144.24K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Talphera, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Talphera, Inc. (TLPH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-12
Talphera, Inc. (TLPH) Q3 2026 Earnings Call Transcript
Positive tone
Early study closure and FDA engagement
Safety and clinical evidence
Clinical trial enrollment challenges
Revenue
$0
▼ 100% YoY EPS
$-0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-12
Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
Confident tone
NefroCRRT trial enrollment progress
Product profile: ease of use and titration
Commercial launch planning
Revenue
$0
EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
Confident tone
NEPHRO Study Enrollment Progress
Nafamostat Clinical Advantages vs. Heparin/Citrate
Cash Position and Financing
Revenue
$0
▼ 100% YoY EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-23
Talphera, Inc. (TLPH) Q4 2025 Earnings Call
Revenue
$0*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript
Positive tone
Nephro study enrollment and site activation
Financing and capital position
Nefamostat product profile and commercial positioning
Revenue
$1,000
EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript
Confident tone
Niyad/nafamostat regulatory and clinical positioning
Heparin and citrate shortages / market need
New site profile strategy and site selection
Revenue
$0
EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript
Confident tone
NEPHRO CRRT trial progress
Compassionate use IDE
Niyad commercial opportunity
Revenue
$27,000
Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Talphera, Inc. (TLPH) Q4 2024 Earnings Call
Revenue
$0*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript
Positive tone
NEPHRO CRRT registrational trial
Trial execution shortfalls and remediation
Regulatory pathway and FDA
Revenue
$0
▼ 100% YoY EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript
Positive tone
Leadership transition and new Chief Development Officer
NEPHRO study progress and site expansion
Financial runway and capital position
Revenue
$0
▼ 100% YoY EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
Positive tone
Market opportunity and pricing for Niyad
Niyad product profile vs. heparin and citrate
NEPHRO CRRT study and enrollment
Revenue
$0
Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-22
Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
Positive tone
Niyad registrational study
Market opportunity for regional anticoagulant
Corporate rebranding and governance
Net income
−$4.52M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Talphera, Inc. (TLPH) Q3 2023 Earnings Call Transcript
Revenue
$117,000
Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Talphera, Inc. (TLPH) Q2 2023 Earnings Call Transcript
Revenue
$253,000
Diluted EPS
$-0.40
▼ 104.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Talphera, Inc. (TLPH) Q1 2023 Earnings Call Transcript
Net income
−$8.15M
EPS
$-0.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Talphera, Inc. (TLPH) Q4 2022 Earnings Call
Revenue
−$442,000*
▼ 22200% YoY Gross margin
181.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Talphera, Inc. (TLPH) Q3 2022 Earnings Call
Revenue
$0
▼ 100% YoY Diluted EPS
$-0.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Talphera, Inc. (TLPH) Q2 2022 Earnings Call
Revenue
$0
▼ 100% YoY Diluted EPS
$8.58
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Talphera, Inc. (TLPH) Q1 2022 Earnings Call
Revenue
$442,000
▼ 13.5% YoY EPS
$-1.19
Gross margin
-77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Talphera, Inc. (TLPH) Q4 2021 Earnings Call
Revenue
$2,000*
▼ 99.7% YoY Gross margin
-61600.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Talphera, Inc. (TLPH) Q3 2021 Earnings Call
Revenue
$1.86M
▲ 36.1% YoY Diluted EPS
$-1.40
Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Talphera, Inc. (TLPH) Q2 2021 Earnings Call
Revenue
$443,000
▼ 84.8% YoY Diluted EPS
$-1.60
Gross margin
-134.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Talphera, Inc. (TLPH) Q1 2021 Earnings Call
Revenue
$511,000
▲ 32.4% YoY EPS
$-1.60
Gross margin
-103.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-15
Talphera, Inc. (TLPH) Q4 2020 Earnings Call
Revenue
$738,000*
▲ 55.4% YoY Gross margin
-76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Talphera, Inc. (TLPH) Q3 2020 Earnings Call
Revenue
$1.37M
▲ 125% YoY Gross margin
-35.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Talphera, Inc. (TLPH) Q4 2019 Earnings Call
Revenue
$475,000
▼ 22.5% YoY Gross margin
-240.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 webcasts
Key facts
CIK
1427925
CUSIP
00444T209
13F (30d)
57 filings
49 filers
Visit website
Investor relations